Recent News

• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Lifecore Biomedical to Participate in Upcoming Investor and Industry Conferences
• 02.03.2025 - Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference
• 01.17.2025 - Lifecore Biomedical Announces Special Stockholder Meeting
• 01.07.2025 - Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million
• 01.06.2025 - Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
• 01.06.2025 - Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
• 01.02.2025 - Q2 2025 Lifecore Biomedical Earnings Conference Call
• 01.02.2025 - Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

Recent Filings

• 02.27.2025 - DEF 14A Other definitive proxy statements
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.05.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 01.21.2025 - PRE 14A Other preliminary proxy statements
• 01.17.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 01.17.2025 - EX-99.1 EX-99.1
• 01.17.2025 - 8-K Current report
• 01.08.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.07.2025 - EX-99.1 EX-99.1